AI
RVMD icon

Alphabet Inc’s Revolution Medicines RVMD Stock Holding History

Alphabet Inc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$320M Sell
3,292,525
-52,577
-2% -$5.31M 7.97% 4
2025
Q4 		$266M Sell
3,345,102
-788,175
-19% -$51.7M 10.33% 3
2025
Q3 		$193M Hold
4,133,277
– – 8.01% 5
2025
Q2 		$152M Hold
4,133,277
– – 7.12% 5
2025
Q1 		$146M Hold
4,133,277
– – 9.27% 4
2024
Q4 		$181M Sell
4,133,277
-122,898
-3% -$6.2M 10.53% 4
2024
Q3 		$193M Sell
4,256,175
-1,050,900
-20% -$45.8M 10.48% 3
2024
Q2 		$206M Buy
5,307,075
+5,563
+0.1% +$208K 10.43% 3
2024
Q1 		$171M Hold
5,301,512
– – 6.8% 6
2023
Q4 		$152M Buy
+5,301,512
New +$127M 7.05% 6

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alphabet Inc's RVMD Position: Q1 2026 in Review

Alphabet Inc reduced its Revolution Medicines (RVMD) stake by 1.6% in Q1 2026, selling an estimated $5.31M and leaving 3,292,525 shares worth $320M. The position accounts for 7.97% of the portfolio, ranked #4.

Alphabet Inc first reported a position in RVMD in Q4 2023 and has held it in 10 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Alphabet Inc held 3,292,525 shares of Revolution Medicines worth $320M as of Q1 2026.
  • Alphabet Inc sold 52,577 Revolution Medicines shares in Q1 2026, an estimated $5.31M.
  • Revolution Medicines made up 7.97% of Alphabet Inc's portfolio in Q1 2026, its #4 holding.
  • Alphabet Inc first reported a position in Revolution Medicines in Q4 2023 and has held it in 10 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.